PGI5 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) COMPARED TO LAMIVUDINE FOR THE TREATMENT OF E ANTIGEN NEGATIVE CHRONIC HEPATITIS B IN THE UK
May 1, 2005, 00:00
10.1016/S1098-3015(10)62994-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)62994-4/fulltext
Title :
PGI5 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) COMPARED TO LAMIVUDINE FOR THE TREATMENT OF E ANTIGEN NEGATIVE CHRONIC HEPATITIS B IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62994-4&doi=10.1016/S1098-3015(10)62994-4
First page :
Section Title :
Open access? :
No
Section Order :
431